Identification of which subgroups of stroke patients could profit from blood pressure reduction or extensive cardiac work up is being investigated in ongoing studies and can be offered alongside standard acute treatment, that is, tissue plasminogen activator (tPA) [12]. This evidence concerns the gene PLAT and Stroke.